The following is a summary of "Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic ...

Pegylated liposomal doxorubicin (PLD ... within 12 months or progressed to uncontrolled or refractory disease after ...

Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory ...

Only a few questions are still open regarding chemotherapy. The MITO-2 trial results will define whether the substitution of paclitaxel with PLD is able to improve PFS and quality of life ...

Expert Rev Anticancer Ther. 2010;10(1):47-60. Both studies showed statistically significant improvements in the median OS and PFS when paclitaxel was used in place of cyclophosphamide. OS ...

Here, the authors propose a model to predict chemotherapy response in breast cancer in real world clinical settings.

Probiotics, like lactic acid bacteria, are non-pathogenic microbes that exert health benefits to the host when administered in adequate quantity. Currently, research is being conducted on the ...

Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic ...